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Table 1
Angular laxity and stiffness in meniscectomized patients (n¼75) and controls
(n¼38)
Unadjusted mean  SE P-value Adjusted mean SE P-value
Patients Controls Patients Controls
Angular laxity, degrees
Varus -9.8  0.4 -8.0  0.4 0.003 -10.0  0.3 -7.8  0.4 0.000
Valgus 6.9  0.2 6.1  0.3 0.019 7.0  0.2 5.8  0.3 0.000
Total 16.8  0.6 14.1  0.6 0.004 17.0  0.5 13.7  0.7 0.000
Stiffness, Nm/
Varus* 1.41  0.05 1.55  0.07 0.074 1.39  0.05 1.58  0.07 0.011
Valgus* 1.88  0.06 1.98  0.10 0.406 1.84  2.05 2.05  0.08 0.056
Midrange* 1.76  0.07 2.21  0.10 0.000 1.74  0.06 2.26  0.09 0.000
*These data were log-transformed for statistical analysis.
Adjusted model include age, sex, height and body mass as covariates.
Figure 1. There is a shift in the mean stance phase knee rotation angle for the anti-
inﬂammatory (Celecoxib) relative to the placebo and analgesic (Oxycodone) arms.
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EFFECT OFA SIX-WEEKCOMBINED HIPAND KNEE NEUROMUSCULAR
EXERCISE PROGRAMME ON JOINT LOADING AND MUSCLE
CO-CONTRACTION IN INDIVIDUALS WITH MEDIAL KNEE
OSTEOARTHRITIS
L. Al-Khlaifat, L. Herrington, A. Hammond, R.K. Jones. Univ. of Salford,
Salford, United Kingdom
Purpose: Medial knee osteoarthritis (OA) is a mechanical condition
affected by the amount of load on the knee joint. This load is deter-
mined by the magnitude of the external knee adduction moment
(EKAM). Moreover, increased muscle co-contraction of the agonist and
antagonist muscles around the knee joint have been reported to
increase with knee OA with the possibility of a further increase in the
loading at the joint. Exercises are a common treatment which have been
shown to decrease pain, improves muscle strength and function.
However, there is a paucity of literature on the effect of exercise regi-
mens on both EKAM and muscle co-contraction and whether exercises
increase or decrease loading on the joint. Previous studies strength-
ening either the quadriceps or hip adductors have found no signiﬁcant
change in EKAMwhich may be due to the type of exercises, the muscles
exercises or method of progression. Therefore, the purpose of this study
was to investigate the effectiveness of a neuromuscular training exer-
cise programme of the hip and knee muscles on EKAM and the co-
contraction of antagonist muscles in knee OA.
Methods: This study was a pilot pre-post design study comparing the
effects of a six-week exercise programme. A convenience sample of 19
participants were recruited from the waiting lists at a local Hospital. 3-
dimensional kinematic (Qualisys OQUS, Gothenburg, Sweden) and
kinetic (AMTI, USA) analysis were collected whilst walking. Surface
electromyography (EMG) data were collected using a Noraxon Telemyo
system (Noraxon, USA) and average normalised activationwas recorded
with electrodes placed on vastus lateralis (VL), vastus medialis (VM),
biceps femoris (BF), and semitendonosis (ST) muscles on the affected
side. Using the Biodex system 3 isokinetic dynamometer (Biodex
Medical Systems, Shirley, N.Y., USA), the average peak torque of the knee
ﬂexors and extensors were assessed concentrically at 60/s and
isometrically at 45, whereas the hip abductors were assessed isomet-
rically at 0 . Clinically, the pain subscale of the Knee injury and Osteo-
arthritis Outcome Score (KOOS) questionnaire. The participants were
assessed at baseline and after the six-week exercise programme and
patient's attendance to the treatment sessions was recorded. Paired t-
tests were used to determine the effects of the exercise programme on
all outcome measures before and after the pilot exercise programme.
Results: Fourteen participants (twelve women and two men, mean age
61.7910.42 years) completed the exercise programme with good
attendance rates (mean 5.36 (SD 0.84) sessions). The EKAM did not
change signiﬁcantly throughout the stance phase on the affected side
though pain and muscle strength signiﬁcantly improved (p<0.05). The
mean difference (standard deviation) and p-values of EKAM during gait
are as follows: in early-stance -0.01 (0.08), p¼ 0.57, in mid-stance -0.01
(0.05), p¼0.70, and in late-stance -0.02 (0.06), p¼0.21. Only muscle co-
contraction between vastus-lateralis and biceps-femoris of the affected
side signiﬁcantly decreased in early and mid-stance (26.68 (34.84),
p¼0.01 and 12.68 (21.07), 0.04, respectively).
Conclusions: The current pilot exercise programme was developed in
an attempt to decrease the load on the knee joint. However, it can beseen from this preliminary data that EKAM did not increase or decrease
signiﬁcantly but muscle co-contraction on the lateral side of the knee
joint decreased which may have reduced total loading on the joint. The
reduced co-contraction may be one way inwhich painwas decreased in
this exercise programme along with the increasedmuscle strength. This
should be conﬁrmed in a larger and longer RCT, as if the EKAM can be
maintainedwith an exercise programmewith increased adherence, rate
of progression could be delayed.
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Purpose: To determine if symptomatic treatment of knee osteoarthritis
is associated with changes in the primary and secondary motions of the
knee during walking. While changes in knee joint loads have been
associated with pain intervention, there is a paucity of information
relating kinematic changes to pain modiﬁcations. Yet kinematic
changes have been implicated in the pathway to knee OA. Speciﬁcally, it
has been suggested changes in the secondary movements of the knee
including anterior-posterior (AP) translation and internal-external (IE)
rotation can contribute to cartilage changes. Therefore the following
hypothesis was tested: Primary (ﬂexion) and secondarymovements (AP
and IE) of the knee are signiﬁcantly different for the two active drug
(Oxycodone and Celecoxib) treatments compared to a double blind
placebo treatment phase.
Methods: A single-blind washout, double blind treatment, double
dummy cross-over pilot study using placebo, Oxycodone HCL and Cel-
ecoxib was used to test the hypothesis. Subjects were randomized to
one of six active treatment sequences. Subjects (n¼6) who met study
eligibility requirements and completed the informed consent process
underwent an initial physician, clinical lab, and radiographic screening.
Eligible subjects had been taking a non-steroidal anti-inﬂammatory 15
of the 30 days prior to enrollment for index knee pain, OA of grade 2 or 3
as deﬁned by the Kellgren and Lawrence grading system of the medial
tibiofemoral joint and met the American College of Rheumatology
clinical classiﬁcation criteria. Subjects were tested in the gait laboratory
at the beginning of each arm of the cross-over study design. Walking
kinematics were collected using the Point Cluster technique marker-set
at self-selected normal pace. External inter-segmental forces and
moments were calculated for the lower limb with inverse dynamics.
Repeated measures ANOVA were used to test for differences in the hip
and knee ﬂexion, adduction, internal external (IE) rotation and the knee
anterior-posterior (AP) translation motions between the three active
treatment phases. Simple linear regressions tested for association
between changes in kinematics and kinetics.
Results: Signiﬁcant differences between Placebo and Celecoxib arms
were found for themean IE knee rotation angle (Figure 1) while changes
in ﬂexion and AP translation did not reach signiﬁcance. In a post-hoc
analysis the change in knee IE rotation was correlated with the change
